INTECH Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

INTECH Investment Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$541K	Sell	24,760 -5,540	-18%	-$115K	0.01%	1312
2026 Q1	$708K	Sell	30,300 -10,493	-26%	-$228K	0.01%	1173
2025 Q4	$857K	Buy	40,793 +6,918	+20%	+$121K	0.01%	1215
2025 Q3	$521K	Sell	33,875 -11,878	-26%	-$155K	﹤0.01%	1560
2025 Q2	$428K	Sell	45,753 -9,911	-18%	-$109K	﹤0.01%	1701
2025 Q1	$684K	Buy	55,664 +23,146	+71%	+$326K	0.01%	1440
2024 Q4	$430K	Buy	32,518 +10,236	+46%	+$175K	﹤0.01%	1644
2024 Q3	$429K	Buy	+22,282	New	+$460K	﹤0.01%	1311

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

INTECH Investment Management's SNDX Position: Q2 2026 in Review

INTECH Investment Management reduced its Syndax Pharmaceuticals (SNDX) stake by 18% in Q2 2026, selling an estimated $115K and leaving 24,760 shares worth $541K. The position accounts for 0.01% of the portfolio, ranked #1312.

INTECH Investment Management first reported a position in SNDX in Q3 2024 and has held it in 8 quarters since. The position peaked at $857K in Q4 2025. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

INTECH Investment Management held 24,760 shares of Syndax Pharmaceuticals worth $541K as of Q2 2026.
INTECH Investment Management sold 5,540 Syndax Pharmaceuticals shares in Q2 2026, an estimated $115K.
Syndax Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1312 holding.
INTECH Investment Management first reported a position in Syndax Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Syndax Pharmaceuticals position peaked at $857K in Q4 2025.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.